Pfizer is currently trading at Rs. 1269.50, up by 27.25 points or 2.19% from its previous closing of Rs. 1242.25 on the BSE.
The scrip opened at Rs. 1250.95 and has touched a high and low of Rs. 1300.85 and Rs. 1233.05 respectively. So far 16641 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1454.90 on 05-Sep-2011 and a 52 week low of Rs. 1071.55 on 30-Dec-2011.
Last one week high and low of the scrip stood at Rs. 1300.85 and Rs. 1204.75 respectively. The current market cap of the company is Rs. 3808.22 crore.
The promoters holding in the company stood at 70.75% while Institutions and Non-Institutions held 9.36% and 19.89% respectively.
Pfizer has reported results for first quarter ended June 30, 2012.
The company’s net profit shot higher by 697.48% at Rs 328.88 crore for the quarter under review as compared to Rs 41.24 crore for the same quarter in the previous year. The total income of the company decreased by 7% at Rs 242.63 crore for Q1FY13 as compared Rs 260.91 crore for the corresponding quarter previous year.
Pfizer manufactures prescription drugs such as Viagra, Lyrica, Viagra, Dolonex Gel, Ponstan, Citralka Liquid, and many more. Its first production unit was set up at Darukhanna in Mumbai.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |